Literature DB >> 1383639

Hepatic resection for a hepatocellular carcinoma larger than 10 cm.

T Furuta1, T Sonoda, T Matsumata, T Kanematsu, K Sugimachi.   

Abstract

Twenty-one patients with hepatocellular carcinoma (HCC) larger than 10 cm diameter were treated during the 18 year period from 1971 to 1988. The mean tumor size was 13 cm (range 10-18 cm). Nineteen patients (90.5%) had subjective symptoms. Eight patients (38.1%) had alpha-fetoprotein (AFP) levels over 10,000 ng/ml, and in 18 patients (85.7%) the levels were over 20 ng/ml. Nevertheless, only three (14.3%) were detected by AFP. Scintigraphy before 1981 and ultrasonography after 1982 appears to be most helpful for detection of HCC. Nineteen lesions (90.5%) were localized in the right hepatic lobe. Large HCC showed a low incidence of histologically verified concomitant cirrhosis (33%; 7 of 21) and a relatively well preserved hepatocellular function (indocyanine green test; 13.9 +/- 6.6%). Curative resection could be done for all 21 patients. There were three (14.3%) operative deaths. The 1-, 3-, and 5-year survival rates were 72.2, 32.9, and 8.2%, respectively. One patient who underwent a left hepatic lobectomy has survived for over 5 years, with recurrence. There were 14 recurrences (66.7%) in 21 patients: 11 were hepatic and three were in the lungs. In patients with large HCC, surgical resection should be done, provided the clinical status and hepatocellular reserves are adequate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383639     DOI: 10.1002/jso.2930510210

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm.

Authors:  Yasuhiko Nagano; Kuniya Tanaka; Shinji Togo; Kenichi Matsuo; Chikara Kunisaki; Mitsutaka Sugita; Daisuke Morioka; Yasuhiko Miura; Toru Kubota; Itaru Endo; Hitoshi Sekido; Hiroshi Shimada
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

2.  Outcomes of surgical resection of super-giant (≥15 cm) hepatocellular carcinoma: Volume does matter, if not the size.

Authors:  Jia Jia Wee; Chin Li Tee; Sameer P Junnarkar; Jee Keem Low; Yen Pin Tan; Cheong Wei Huey; Vishal G Shelat
Journal:  J Clin Transl Res       Date:  2022-05-25

3.  Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

Review 4.  Surgical treatment of hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

5.  Surgery for large primary liver cancer more than 10 cm in diameter.

Authors:  Xin-Da Zhou; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Lun-Xiu Qin; Bo-Heng Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-30       Impact factor: 4.553

Review 6.  Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review.

Authors:  Yan-Ming Zhou; Bin Li; Dong-Hui Xu; Jia-Mei Yang
Journal:  Med Sci Monit       Date:  2011-02-25

7.  Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.

Authors:  Ye Xin Koh; Hwee Leong Tan; Weng Kit Lye; Juinn Huar Kam; Adrian Kah Heng Chiow; Siong San Tan; Su Pin Choo; Alexander Yaw Fui Chung; Brian Kim Poh Goh
Journal:  World J Hepatol       Date:  2018-06-27

8.  Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.

Authors:  Wei-Lun Tsai; Kwok-Hung Lai; Huei-Lung Liang; Ping-I Hsu; Hoi-Hung Chan; Wen-Chi Chen; Hsien-Chung Yu; Feng-Woei Tsay; Huay-Min Wang; Hung-Chih Tsai; Jin-Shiung Cheng
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

9.  Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma.

Authors:  Wei-Lun Tsai; Wei-Chi Sun; Wen-Chi Chen; Chia-Ling Chiang; Huey-Shyan Lin; Huei-Lung Liang; Jin-Shiung Cheng
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.